New concepts in C. difficile management

Br Med Bull. 2019 Sep 19;131(1):109-118. doi: 10.1093/bmb/ldz029.

Abstract

Background: Clostridium difficile infection is transmitted via spores, and the disease is mediated via secreted toxins. It represents a significant healthcare problem, and clinical presentation can range from asymptomatic carriage to life-threatening pseudomembranous colitis.

Sources of data: publications in the field, with a focus on recent developments and concepts.

Areas of agreement: infection control measures, antibiotic stewardship and current management of the initial episode of C. difficile infection.

Areas of controversy: selection and sequence of interventions for the management of recurrent C. difficile infection; management of persistent carriers of toxigenic C. difficile in patients at high risk of subsequent C. difficile infection.

Growing points: use of faecal microbiota transplantation for recurrent C. difficile infection.

Areas timely for developing research: role of specific microbiota-mediated interventions and vaccination in the treatment and prevention of C. difficile infection.

Keywords: antibiotics; colitis; diarrhoea; microbiota.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Vaccines
  • Clostridioides difficile*
  • Clostridium Infections / prevention & control*
  • Clostridium Infections / transmission
  • Drug Therapy, Combination
  • Feces / microbiology
  • Humans
  • Infection Control / methods
  • Inflammatory Bowel Diseases / microbiology
  • Recurrence
  • Risk Factors

Substances

  • Anti-Bacterial Agents
  • Bacterial Vaccines